參考資料
- You QS et al. Prevalence and Causes of Visual Impairment and Blindness among Adult Chinese in Hong Kong The Hong Kong Eye Study. Ophthalmic Epidemiol. 2020 Oct;27(5):354-363.
- Age-related macular degeneration (AMD). NHS.2021. Available from: https://www.nhs.uk/conditions/age-related-macular-degeneration-amd/
- 老年黃斑病變. 香港中文大學眼科及視覺科學學系. 2021. Available from: https://www.ovs.cuhk.edu.hk/zh/眼病小字典/老年黃斑病變病理和治療/.
- Iu LP, Kwok AK. An update of treatment options for neovascular age-related macular degeneration. Hong Kong Med J. 2007 Dec;13(6):460-70.
- Macular degeneration treatments – AMDF. American Macular Degeneration Foundation. 2022. Available from: https://www.macular.org/care-and-treatment/treatments.
- Mueller SB, Kontos CD. Tie1: An orphan receptor provides context for angiopoietin-2/tie2 signaling. J Clin Invest. 2016 Sep 1;126(9):3188-91.
- Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006 Dec;27(12):552-8.
- Hobbs SD, Pierce K. Wet Age-related Macular Degeneration (Wet AMD). National Library of Medicine. StatPearls; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572147/.
- Age-related macular degeneration. The American Society of Retina Specialists. Available from: https://www.asrs.org/patients/age-related-macular-degeneration.
- Wet macular degeneration. Mayo Clinic. Mayo Foundation for Medical Education and Research; 2020. Available from:https://www.mayoclinic.org/zh-hans/diseases-conditions/wet-macular-degeneration/symptoms-causes/syc-20351107.
- Fluorescein Angiography. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.org/Fluorescein_Angiography.
- Intravitreal Injections Patients The American Society of Retina Specialists. Available from: https://www.asrs.org/patients/retinal-diseases/33/intravitreal-injections.
- Ranibizumab intravitreal injection (Rx). Medscape.2022. Available from: https://reference.medscape.com/drug/lucentis-byooviz-ranibizumab-intravitreal-injection-343645.
- Aflibercept intravitreal (Rx). Medscape. 2023. Available from: https://reference.medscape.com/drug/eylea-aflibercept-intravitreal-999705.
- Brolucizumab intravitreal (Rx). 2022. Available from: https://reference.medscape.com/drug/beovu-brolucizumab-intravitreal-1000350.
- Moorfields Eye Hospital. Patient Information. Anti-VEGF intravitreal injection treatment – NHS. Available from:https://www.moorfields.nhs.uk/sites/default/files/uploads/documents/Patient%20information%20-%20intravitreal%20injections%20for%20AMD.pdf.
- Faricimab. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.aao.org/Faricimab.
- Nicolò M, et al. Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. Expert Opin Investig Drugs. 2021 Mar;30(3):193-200.
- Vabysmo. Summary of Product Characteristics.
- Photodynamic therapy (PDT). EyeWiki. American Academy of Ophthalmology; 2017. Available from: https://eyewiki.aao.org/Photodynamic_Therapy_(PDT).
- Photodynamic therapy for age-related macular degeneration. Photodynamic Therapy for Age-Related Macular Degeneration. Johns Hopkins Medicine; 2021. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/photodynamic-therapy-for-agerelated-macular-degeneration.
- Photodynamic Therapy: What You Can Expect. Kellogg Eye Center. 2016. Available from: https://www.med.umich.edu/1libr/Ophthalmology/OcularOncology/PhotodynamicTherapy-nonCancer.pdf.
- Laser Photocoagulation for Age-Related Macular Degeneration . Johns Hopkins Medicine. 2021. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/laser-photocoagulation-for-agerelated-macular-degeneration.
- Panretinal Photocoagulation Laser (PRP). NHS choices. NHS; 2019. Available from: https://www.hey.nhs.uk/patient-leaflet/panretinal-photocoagulation-laser-prp/.
- Bressler N, et al. Optimizing management of diabetic macular edema in Hong Kong: a collaborative position paper. Hong Kong J Ophthalmol. 2017Sep.25 ;21(2):59-64.
- Musat O. Diabetic Macular Edema. Romanian Journal of Pohthalmology. 2015;59(3):133–6.
- Ciulla TA, et al. Diabetic retinopathy and diabetic macular edema. Diabetes Care. 2003;26(9):2653–64.
- Sahni J, et al. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. Ophthalmology. 2019 Aug;126(8):1155-1170.
- Diep TM, Tsui I. Risk factors associated with diabetic macular edema. Diabetes Research and Clinical Practice. 2013Jun;100(3):298–305.
- Acan D, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018 Apr 12;18(1):91.
- Overview -Diabetic retinopathy. NHS choices. NHS; 2021. Available from: https://www.nhs.uk/conditions/diabetic-retinopathy/.
- Diabetic Macular Edema. EyeWiki. American Academy of Ophthlamology; 2022. Available from:https://eyewiki.org/Diabetic_Macular_Edema.
- Patient Information. Laser treatment for diabetic macular oedema. Moorfields Eye Hospital. 2013. Available from: https://www.moorfields.nhs.uk/sites/default/files/uploads/documents/Patient%20information%20-%20laser%20for%20diabetic%20macula%20oedema.pdf.
- Intravitreal Injections. Hull University Teaching Hospitals NHS Trust. 2021. Available from: https://www.hey.nhs.uk/patient-leaflet/intravitreal-injections/
- Retinal Photodynamic Therapy (PDT). Hull University Teaching Hospitals NHS Trust. 2019. Available from: https://www.hey.nhs.uk/patient-leaflet/retinal-photodynamic-therapy-pdt/.